CCR5 has been confirmed to be overexpressed in a variety of tumors and affects patient prognosis (Hemmatazad and Berger 2021), such as esophageal, pancreatic, and neck cancers (Aldinucci and Colombatti 2014; Jiao et al., 2019). The gene discussed is CCR5; the disease is malignant tumor of neck.